|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/23/24 Acco Brands Corp. 10-K 12/31/23 132:22M Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 4.97M
2: EX-19 Report Furnished to Security Holders HTML 66K
3: EX-21.1 Subsidiaries List HTML 46K
4: EX-23.1 Consent of Expert or Counsel HTML 37K
5: EX-24.1 Power of Attorney HTML 51K
10: EX-97 Clawback Policy re: Recovery of Erroneously HTML 54K
Awarded Compensation
6: EX-31.1 Certification -- §302 - SOA'02 HTML 42K
7: EX-31.2 Certification -- §302 - SOA'02 HTML 42K
8: EX-32.1 Certification -- §906 - SOA'02 HTML 39K
9: EX-32.2 Certification -- §906 - SOA'02 HTML 39K
12: R1 Cover page HTML 103K
13: R2 Audit Information HTML 42K
14: R3 Consolidated Balance Sheets HTML 161K
15: R4 Consolidated Balance Sheets (Parenthetical) HTML 54K
16: R5 Consolidated Statements of (Loss) Income HTML 133K
17: R6 Consolidated Statements of Comprehensive (Loss) HTML 67K
Income
18: R7 Consolidated Statements of Comprehensive (Loss) HTML 45K
Income (Parenthetical)
19: R8 Consolidated Statements of Cash Flows HTML 149K
20: R9 Consolidated Statements of Stockholders? Equity HTML 101K
21: R10 Consolidated Statements of Stockholders' Equity HTML 39K
(Parenthetical)
22: R11 Pay vs Performance Disclosure HTML 49K
23: R12 Insider Trading Arrangements HTML 46K
24: R13 Basis of Presentation HTML 42K
25: R14 Significant Accounting Policies, Recent Accounting HTML 116K
Pronouncements and Adopted Accounting Standards
26: R15 Long-term Debt and Short-term Borrowings HTML 125K
27: R16 Leases HTML 90K
28: R17 Pension and Other Retiree Benefits HTML 707K
29: R18 Stock-Based Compensation HTML 168K
30: R19 Inventories HTML 52K
31: R20 Property, Plant and Equipment, Net HTML 64K
32: R21 Goodwill and Identifiable Intangible Assets HTML 160K
33: R22 Restructuring HTML 141K
34: R23 Income Taxes HTML 264K
35: R24 Earnings Per Share HTML 68K
36: R25 Derivative Financial Instruments HTML 118K
37: R26 Fair Value of Financial Instruments HTML 62K
38: R27 Accumulated Other Comprehensive Income (Loss) HTML 133K
39: R28 Revenue Recognition HTML 103K
40: R29 Information on Business Segments HTML 237K
41: R30 Commitments and Contingencies HTML 61K
42: R31 Valuation and Qualifying Accounts and Reserves HTML 148K
43: R32 Significant Accounting Policies, Recent Accounting HTML 168K
Pronouncements and Adopted Accounting Standards
(Policies)
44: R33 Significant Accounting Policies, Recent Accounting HTML 68K
Pronouncements and Adopted Accounting Standards
(Tables)
45: R34 Long-term Debt and Short-term Borrowings (Tables) HTML 97K
46: R35 Leases (Tables) HTML 90K
47: R36 Pension and Other Retiree Benefits (Tables) HTML 700K
48: R37 Stock-Based Compensation (Tables) HTML 147K
49: R38 Inventories (Tables) HTML 52K
50: R39 Property, Plant and Equipment (Tables) HTML 68K
51: R40 Goodwill and Identifiable Intangible Assets HTML 154K
(Tables)
52: R41 Restructuring (Tables) HTML 138K
53: R42 Income Taxes (Tables) HTML 234K
54: R43 Earnings Per Share (Tables) HTML 60K
55: R44 Derivative Financial Instruments (Tables) HTML 112K
56: R45 Fair Value of Financial Instruments (Tables) HTML 50K
57: R46 Accumulated Other Comprehensive Income (Loss) HTML 133K
(Tables)
58: R47 Revenue Recognition (Tables) HTML 93K
59: R48 Information on Business Segments (Tables) HTML 216K
60: R49 Commitments and Contingencies (Tables) HTML 50K
61: R50 Basis of Presentation - Narrative (Details) HTML 42K
62: R51 Significant Accounting Policies, Recent Accounting HTML 111K
Pronouncements and Adopted Accounting Standards -
Narrative (Details)
63: R52 Acquisitions - Allocation of Consideration Given HTML 41K
to Fair Value of Assets Acquired and Liabilities
Assumed (Details)
64: R53 Long-term Debt and Short-term Borrowings - Summary HTML 68K
of Notes Payable and Long-Term Debt (Details)
65: R54 Long-term Debt and Short-term Borrowings - Summary HTML 63K
of Notes Payable and Long-Term Debt
(Parenthetical) (Details)
66: R55 Long-term Debt and Short-term Borrowings - HTML 128K
Narrative (Details)
67: R56 Long-term Debt and Short-term Borrowings - HTML 51K
Schedule of Maximum Consolidated Leverage Ratio
(Details)
68: R57 Long-term Debt and Short-term Borrowings - HTML 76K
Schedule of Applicable Rate and Undrawn Fee Based
on Company's Consolidated Leverage Ratio (Details)
- Secured Debt (Details)
69: R58 Leases - Components of Lease Expense (Details) HTML 43K
70: R59 Leases - Summary of Other Information (Details) HTML 46K
71: R60 Leases - Schedule of Future Minimum Lease HTML 56K
Payments, Net of Sub-Lease Income (Details)
72: R61 Pension and Other Retiree Benefits - Pension HTML 138K
Benefit Obligation and Funded Status (Details)
73: R62 Pension and Other Retiree Benefits (Accumulated HTML 48K
Benefit Obligations in Excess of Plan Assets)
(Details)
74: R63 Pension and Other Retiree Benefits - Projected HTML 47K
Benefit Obligations in Excess of Plan Assets
(Details)
75: R64 Pension and Other Retiree Benefits - Net Periodic HTML 81K
Benefit Expense (Details)
76: R65 Pension and Other Retiree Benefits - Other Changes HTML 66K
Recognized in Accumulated Other Comprehensive
Income (Details)
77: R66 Pension and Other Retiree Benefits - Weighted HTML 49K
Average Assumptions Used in Calculating Benefit
Obligation (Details)
78: R67 Pension and Other Retiree Benefits - Weighted HTML 52K
Average Assumptions Used In Calculating Net
Periodic Benefit Cost (Details)
79: R68 Pension and Other Retiree Benefits - Assumed HTML 45K
Health Care Cost Trend Rates (Details)
80: R69 Pension and Other Retiree Benefits - Weighted HTML 59K
Average Asset Allocation (Details)
81: R70 Pension and Other Retiree Benefits - Fair Value of HTML 126K
Plan Assets (Details)
82: R71 Pension and Other Retiree Benefits - Estimated HTML 54K
Future Benefit Payments (Details)
83: R72 Pension and Other Retiree Benefits - HTML 62K
Multi-Employer (Details)
84: R73 Pension and Other Retiree Benefits - Narrative HTML 77K
(Details)
85: R74 Stock-Based Compensation - Narrative (Details) HTML 110K
86: R75 Stock-Based Compensation - Share-Based HTML 46K
Compensation Expense by Line Item (Details)
87: R76 Stock-Based Compensation - Share-based HTML 54K
Compensation Expense (Details)
88: R77 Stock-Based Compensation - Weighted Average HTML 56K
Assumptions (Details)
89: R78 Stock-Based Compensation - Stock Option Activity HTML 67K
(Details)
90: R79 Stock-Based Compensation - Stock Units Rollforward HTML 82K
(Details)
91: R80 Inventories - Components of Inventories (Details) HTML 46K
92: R81 Property, Plant and Equipment, Net (Details) HTML 63K
93: R82 Goodwill and Identifiable Intangible Assets - HTML 60K
Narrative (Details)
94: R83 Goodwill and Identifiable Intangible Assets - HTML 57K
Summary of Changes in Net Carrying Amount Goodwill
By Segment (Details)
95: R84 Goodwill and Identifiable Intangible Assets - HTML 74K
Summary of Gross Carrying Value and Accumulated
Amortization By Class of Identifiable Intangible
Assets (Details)
96: R85 Goodwill and Identifiable Intangible Assets - HTML 49K
Amortization Expense and Estimated Future
Amortization (Details)
97: R86 Restructuring (Restructuring Charges and HTML 71K
Reconciliation) (Details)
98: R87 Restructuring (Restructuring Charges) (Details) HTML 61K
99: R88 Income Taxes - Components of (Loss) Income Before HTML 47K
Taxes (Details)
100: R89 Income Taxes - Effective Income Tax Rate HTML 81K
Reconciliation (Details)
101: R90 Income Taxes - Components of Income Tax (Details) HTML 58K
102: R91 Income Taxes - Components of Deferred Tax Assets HTML 84K
(Liabilities) (Details)
103: R92 Income Taxes - Schedule of Unrecognized Tax HTML 46K
Benefits (Details)
104: R93 Income Taxes - Narrative (Details) HTML 147K
105: R94 Earnings Per Share - Narrative (Details) HTML 47K
106: R95 Earnings Per Share - Summary of Number of HTML 52K
Weighted-Average Shares Outstanding (Details)
107: R96 Derivative Financial Instruments - Narrative HTML 45K
(Details)
108: R97 Derivative Financial Instruments - Fair Value of HTML 58K
Derivative Instruments (Details)
109: R98 Derivative Financial Instruments - Effect of HTML 53K
Derivative Instruments (Details)
110: R99 Fair Value of Financial Instruments - Schedule of HTML 42K
Fair Value Assets and Liabilities Measured on a
Recurring Basis (Details)
111: R100 Fair Value of Financial Instruments - Narrative HTML 44K
(Details)
112: R101 Accumulated Other Comprehensive Income (Loss) - HTML 61K
Schedule of Accumulated Other Comprehensive Income
(Loss) (Details)
113: R102 Accumulated Other Comprehensive Income (Loss) - HTML 80K
Reclassification out of AOCI (Details)
114: R103 Revenue Recognition - Service or Extended HTML 41K
Maintenance Agreements (Details)
115: R104 Revenue Recognition - Unearned Revenue (Details) HTML 45K
116: R105 Revenue Recognition - Schedule of Disaggregation HTML 69K
of Revenue (Details)
117: R106 Information on Business Segments - Narrative HTML 52K
(Details)
118: R107 Information on Business Segments - Net Sales by HTML 52K
Segment (Details)
119: R108 Information on Business Segments - Schedule of HTML 74K
Operating (Loss) Income by Business Segment
(Details)
120: R109 Information on Business Segments - Assets by HTML 61K
Segment (Details)
121: R110 Information on Business Segments - Identifiable HTML 54K
Intangibles and Goodwill by Segment (Details)
122: R111 Information on Business Segments - Capital Spend HTML 46K
by Segment (Details)
123: R112 Information on Business Segments - Depreciation HTML 46K
Expense by Segment (Details)
124: R113 Information on Business Segments - Property, Plant HTML 62K
and Equipment by Geographic Region (Details)
125: R114 Commitments and Contingencies - Narrative HTML 48K
(Details)
126: R115 Commitments and Contingencies - Purchase HTML 50K
Commitments (Details)
127: R116 Valuation and Qualifying Accounts and Reserves HTML 63K
(Details)
129: XML IDEA XML File -- Filing Summary XML 255K
132: XML XBRL Instance -- acco-20231231_htm XML 6.49M
128: EXCEL IDEA Workbook of Financial Report Info XLSX 273K
11: EX-101.SCH XBRL Taxonomy Extension Schema With Embedded XSD 6.38M
Linkbases Document -- acco-20231231
130: JSON XBRL Instance as JSON Data -- MetaLinks 825± 1.32M
131: ZIP XBRL Zipped Folder -- 0000950170-24-019211-xbrl Zip 873K
| EX-19 |
Exhibit 19
ACCO BRANDS CORPORATION
Insider Trading Compliance Policy and Procedures
Federal and state laws prohibit trading in the securities of a company while in possession of material nonpublic information and in breach of a duty of trust or confidence. These laws also prohibit anyone who is aware of material nonpublic information from providing this information to others who may trade. Violating such laws can undermine investor trust, harm the reputation and integrity of ACCO Brands Corporation (together with its subsidiaries, the “Company”), and result in dismissal from the Company or even serious criminal and civil charges against the individual and the Company. The Company reserves the right to take whatever disciplinary or other measure(s) it determines in its sole discretion to be appropriate in any particular situation, including disclosure of wrongdoing to governmental authorities.
Persons Covered and Administration of Policy
This Insider Trading Compliance Policy and Procedures (this “Policy”) applies to all officers, directors and employees of the Company. For purposes of this Policy, “officers” refer to those individuals who meet the definition of “officer” under Section 16 of the Securities Exchange Act of 1934 (as amended, the “Exchange Act”). Individuals subject to this Policy are responsible for ensuring that members of their household comply with this Policy. This Policy also applies to any entities controlled by individuals subject to the Policy, including any corporations, limited liability companies, partnerships or trusts, and transactions by these entities should be treated for the purposes of this Policy as if they were for the individual’s own account. The Company may determine that this Policy applies to additional persons with access to material nonpublic information, such as contractors or consultants. Officers, directors and employees, together with any other person designated as being subject to this Policy by the General Counsel or his or her designee (the “Compliance Officer”), are referred to collectively as “Covered Persons.”
Questions regarding the Policy should be directed to the Compliance Officer, who is responsible for the administration of this Policy.
Policy Statement
No Covered Person shall purchase or sell any type of security while in possession of material nonpublic information relating to the security or the issuer of such security in breach of a duty of trust or confidence, whether the issuer of such security is the Company or any other company. In addition, if a Covered Person is in possession of material nonpublic information about other publicly-traded companies, such as suppliers, customers, competitors or potential acquisition targets, the Covered Person may not trade in such other companies’ securities until the information becomes public or is no longer material. Further, no Covered Person shall purchase or sell any security of any other company, including another company in the Company’s industry, while in possession of material nonpublic information if such information is obtained in the course of the Covered Person’s employment or service with the Company.
In addition, Covered Persons shall not directly or indirectly communicate material nonpublic information to anyone outside the Company (except in accordance with the Company’s policies regarding confidential information) or to anyone within the Company other than on a “need-to-know” basis.
“Securities” includes stocks, bonds, notes, debentures, options, warrants, equity and other convertible securities, as well as derivative instruments.
“Purchase” and “sale” are defined broadly under the federal securities law. “Purchase” includes not only the actual purchase of a security, but also any contract to purchase or otherwise acquire a security. “Sale” includes not only the actual sale of a security, but also any contract to sell or otherwise dispose of a security. These definitions extend to a broad range of transactions, including conventional cash-for-stock transactions, conversions, the exercise of stock options, transfers, gifts, and acquisitions and exercises of warrants or puts, calls, pledging and margin loans, or other derivative securities.
The laws and regulations concerning insider trading are complex, and Covered Persons are encouraged to seek guidance from the Compliance Officer prior to considering a transaction in Company securities.
Blackout Periods
No director, officer or employee meeting the criteria listed on Schedule I, as determined by the Compliance Officer from time to time, (as well as any individual or entity covered by this Policy by virtue of their relationship to such director, officer or employee) shall purchase or sell any security of the Company during the period beginning on the 15th calendar day of the last month of any fiscal quarter of the Company and ending after completion of the second full trading day after the public release of earnings data for such fiscal quarter or during any other trading suspension period declared by the Company, such period, a “blackout period.” A “trading day” is a day on which U.S. national stock exchanges are open for trading. If, for example, the Company were to make an announcement on Monday prior to 9:30 a.m. Eastern Time, then the blackout period would terminate after the close of trading on Tuesday. If an announcement were made on Monday after 9:30 a.m. Eastern Time, then the blackout period would terminate after the close of trading on Wednesday. If you have any question as to whether information is publicly available, please direct an inquiry to the Compliance Officer.
These prohibitions do not apply to:
Exceptions to the blackout period policy may be approved by the Compliance Officer or, in the case of exceptions for directors, the Board of Directors with advice of counsel.
The Compliance Officer may recommend that directors, officers, employees or others suspend trading in Company securities because of developments that have not yet been disclosed to the public. Subject to the exceptions noted above, all of those individuals affected should not trade in the Company’s securities while the suspension is in effect and should not disclose to others that the Company has suspended trading.
Preclearance of Trades by Directors, Officers and Employees
All transactions in the Company’s securities by directors, officers, and employees meeting the criteria listed on Schedule II, as determined by the Compliance Officer from time to time, (each, a “Preclearance Person”) must be precleared by the Compliance Officer and the Chief Financial Officer. Transactions by the Compliance Officer or the Chief Financial Officer must be precleared by the CEO and, for transactions by the Compliance Officer, the Chief Financial Officer and, for transactions by the Chief Financial Officer, the Compliance Officer. Preclearance should not be understood to represent legal advice by the company that a proposed transaction complies with the law.
A request for preclearance must be in writing, should be made at least two business days in advance of the proposed transaction, and should include the identity of the Preclearance Person, a description of the proposed transaction, the proposed date of the transaction, and the number of shares or other securities involved. In addition, the Preclearance Person must execute a certification that he or she is not aware of material nonpublic information about the Company. The Compliance Officer and the Chief Financial Officer, or the CEO and Chief Financial Officer for transactions by the Compliance Officer and the CEO and Compliance Officer for transactions by the Chief Financial Officer, shall have sole discretion to decide whether to clear any contemplated transaction. All trades that are precleared must be effected within five business days of receipt of the preclearance. A precleared trade (or any portion of a precleared trade) that has not been effected during the five business day period must be submitted for preclearance determination again prior to execution. Notwithstanding receipt of preclearance, if the Preclearance Person becomes aware of material nonpublic information or becomes subject to a blackout period
before the transaction is effected, the transaction may not be completed. Transactions under a previously established Rule 10b5-1 Trading Plan that has been preapproved in accordance with this Policy are not subject to further preclearance.
None of the Company, the CEO, the Compliance Officer or the Chief Financial Officer, or the Company’s other employees will have any liability for any delay in reviewing, or refusal of, a request for preclearance.
Material Nonpublic Information
Information is considered “material” if there is a substantial likelihood that a reasonable investor would consider it important in making a decision to buy, sell, or hold a security, or if the information is likely to have a significant effect on the market price of the security. Material information can be positive or negative and can relate to virtually any aspect of a company’s business or to any type of security, debt, or equity. Also, information that something is likely to happen in the future—or even just that it may happen—could be deemed material.
Examples of material information may include (but are not limited to) information about:
Information is “nonpublic” if it is not available to the general public. In order for information to be considered “public,” it must be widely disseminated in a manner that makes it generally available to investors in a Regulation FD-compliant method, such as through a press release, a filing with the U.S. Securities and Exchange Commission (the “SEC”) or a Regulation FD-compliant conference call. The Compliance Officer shall have sole discretion to decide whether information is public for purposes of this Policy.
The circulation of rumors, even if accurate and reported in the media, does not constitute public dissemination. In addition, even after a public announcement, a reasonable period of time
may need to lapse in order for the market to react to the information. Generally, the passage of two full trading days following release of the information to the public, is a reasonable waiting period before such information is deemed to be public.
Post-Termination Transactions
If an individual is in possession of material nonpublic information when the individual’s service terminates, the individual may not trade in the Company’s securities until that information has become public or is no longer material.
Prohibited Transactions
The Company has determined that there is a heightened legal risk and the appearance of improper or inappropriate conduct if persons subject to this Policy engage in certain types of transactions. Therefore, Covered Persons shall comply with the following policies with respect to certain transactions in the Company’s securities.
Short Sales
Short sales of the Company’s securities are prohibited by this Policy. Short sales of the Company’s securities, or sales of shares that the insider does not own at the time of sale, or sales of shares against which the insider does not deliver the shares within 20 days after the sale, evidence an expectation on the part of the seller that the securities will decline in value, and, therefore, signal to the market that the seller has no confidence in the Company or its short-term prospects. In addition, Section 16(c) of the Exchange Act prohibits Section 16 reporting persons (i.e., directors, officers, and the Company’s 10% stockholders) from making short sales of the Company’s equity securities.
Options
Transactions in puts, calls, or other derivative securities involving the Company’s equity securities, on an exchange, on an over-the-counter market, or in any other organized market, are prohibited by this Policy. A transaction in options is, in effect, a bet on the short-term movement of the Company’s stock and, therefore, creates the appearance that a Covered Person is trading based on material nonpublic information. Transactions in options, whether traded on an exchange, on an over-the-counter market, or any other organized market, also may focus a Covered Person’s attention on short-term performance at the expense of the Company’s long-term objectives.
Hedging Transactions
Hedging transactions involving the Company’s securities, such as prepaid variable forward contracts, equity swaps, collars and exchange funds, or other transactions that hedge or offset, or are designed to hedge or offset, any decrease in the market value of the Company’s equity securities, are prohibited by this Policy. Such transactions allow the Covered Person to continue to own the covered securities, but without the full risks and rewards of ownership. When that
occurs, the Covered Person may no longer have the same objectives as the Company’s other stockholders.
Margin Accounts and Pledging
Individuals are prohibited from pledging Company securities as collateral for a loan, purchasing Company securities on margin (i.e., borrowing money to purchase the securities), or placing Company securities in a margin account. This prohibition does not apply to cashless exercises of stock options under the Company’s equity plans, nor to situations approved in advance by the Compliance Officer.
Partnership Distributions
Nothing in this Policy is intended to limit the ability of an investment fund, venture capital partnership or other similar entity with which a director is affiliated to distribute Company securities to its partners, members, or other similar persons. It is the responsibility of each affected director and the affiliated entity, in consultation with their own counsel (as appropriate), to determine the timing of any distributions, based on all relevant facts and circumstances, and applicable securities laws.
Rule 10b5-1 Trading Plans
The trading restrictions set forth in this Policy, other than those transactions described under “Prohibited Transactions,” do not apply to transactions under a previously established contract, plan or instruction to trade in the Company’s securities entered into in accordance with Rule 10b5-1 (a “Trading Plan”) that:
The Compliance Officer may impose such other conditions on the implementation and operation of the Trading Plan as the Compliance Officer deems necessary or advisable. Individuals may not adopt more than one Trading Plan at a time except under the limited circumstances permitted by Rule 10b5-1 and subject to preapproval by the Compliance Officer.
An individual may only modify a Trading Plan outside of a blackout period and, in any event, when the individual does not possess material nonpublic information. Modifications to and terminations of a Trading Plan are subject to preapproval by the Compliance Officer and modifications of a Trading Plan that change the amount, price, or timing of the purchase or sale of the securities underlying a Trading Plan will trigger a new Cooling-Off Period.
The Company reserves the right to publicly disclose, announce, or respond to inquiries from the media regarding the adoption, modification, or termination of a Trading Plan and non-Rule 10b5-1 trading arrangements, or the execution of transactions made under a Trading Plan. The Company also reserves the right from time to time to suspend, discontinue, or otherwise prohibit transactions under a Trading Plan if the Compliance Officer or the Board of Directors, in its discretion, determines that such suspension, discontinuation, or other prohibition is in the best interests of the Company.
Compliance of a Trading Plan with the terms of Rule 10b5-1 and the execution of transactions pursuant to the Trading Plan are the sole responsibility of the person initiating the Trading Plan, and none of the Company, the Compliance Officer, or the Company’s other employees assumes any liability for any delay in reviewing and/or refusing to approve a Trading Plan submitted for approval, nor the legality or consequences relating to a person entering into, informing the Company of, or trading under, a Trading Plan.
Interpretation, Amendment, and Implementation of this Policy
The General Counsel shall have the authority to interpret and update this Policy and all related policies and procedures. In particular, such interpretations and updates of this Policy, as authorized by the General Counsel, may include amendments to or departures from the terms of this Policy, to the extent consistent with the general purpose of this Policy and applicable securities laws.
Actions taken by the Company, the General Counsel, the Compliance Officer (if someone other than the General Counsel), or any other Company personnel do not constitute legal advice, nor do they insulate you from the consequences of noncompliance with this Policy or with securities laws.
Certification of Compliance
All directors, officers, employees and others subject to this Policy may be asked periodically to certify their compliance with the terms and provisions of this Policy.
Effective August 1, 2023
Schedule I
Individuals Subject to Quarterly Trading Blackouts
[All directors, executive officers, anyone who reports directly to an executive officer, and other individuals with access to the global financial consolidation and reporting system or regular access to material non-public information]
Schedule II
Individuals Subject to Preclearance Requirement TC "Schedule II Individuals Subject to Preclearance Requirement" \f C \l "2"
[All directors and executive officers, and certain other persons with regular access to material non-public information identified by the Compliance Officer]
| This ‘10-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 2/23/24 | None on these Dates | ||
| For Period end: | 12/31/23 | |||
| 8/1/23 | ||||
| List all Filings | ||||